Literature DB >> 35096682

Rapid decay of anti-SARS-CoV-2 antibodies in infection-naïve healthcare workers four months after vaccination.

Maria Stamatopoulou1, Vasileios Tsamadias2, Theodosios Theodosopoulos3, Stiliani Demeridou4, George Kaparos5, Nikolaos Memos3, Manoussos Konstadoulakis3, Stavroula Baka6.   

Abstract

Entities:  

Keywords:  BNT162b2 mRNA COVID-19 vaccine; COVID-19; SARS-CoV-2; anti-SARS-CoV-2 IgG antibodies decline; anti-spike RBD IgG antibody; healthcare workers; humoral immune response

Year:  2021        PMID： 35096682      PMCID： PMC8789353          DOI： 10.18683/germs.2021.1300

Source DB:  PubMed          Journal:  Germs        ISSN： 2248-2997


× No keyword cloud information.
  12 in total

1.  Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination.

Authors:  Lisa Müller; Marcel Andrée; Wiebke Moskorz; Ingo Drexler; Lara Walotka; Ramona Grothmann; Johannes Ptok; Jonas Hillebrandt; Anastasia Ritchie; Denise Rabl; Philipp Niklas Ostermann; Rebekka Robitzsch; Sandra Hauka; Andreas Walker; Christopher Menne; Ralf Grutza; Jörg Timm; Ortwin Adams; Heiner Schaal
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

2.  The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.

Authors:  Gabriel Chodick; Lilac Tene; Ran S Rotem; Tal Patalon; Sivan Gazit; Amir Ben-Tov; Clara Weil; Inbal Goldshtein; Gilad Twig; Dani Cohen; Khitam Muhsen
Journal:  Clin Infect Dis       Date:  2022-02-11       Impact factor: 9.079

3.  SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.

Authors:  Jackson S Turner; Wooseob Kim; Elizaveta Kalaidina; Charles W Goss; Adriana M Rauseo; Aaron J Schmitz; Lena Hansen; Alem Haile; Michael K Klebert; Iskra Pusic; Jane A O'Halloran; Rachel M Presti; Ali H Ellebedy
Journal:  Nature       Date:  2021-05-24       Impact factor: 49.962

Review 4.  COVID-19: Characteristics and Therapeutics.

Authors:  Rameswari Chilamakuri; Saurabh Agarwal
Journal:  Cells       Date:  2021-01-21       Impact factor: 6.600

5.  Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in healthcare workers.

Authors:  Ayşen Bayram; Hadiye Demirbakan; Pınar Günel Karadeniz; Merve Erdoğan; Ipek Koçer
Journal:  J Med Virol       Date:  2021-05-31       Impact factor: 20.693

6.  Evolution of antibody immunity to SARS-CoV-2.

Authors:  Christian Gaebler; Zijun Wang; Julio C C Lorenzi; Frauke Muecksch; Shlomo Finkin; Minami Tokuyama; Alice Cho; Mila Jankovic; Dennis Schaefer-Babajew; Thiago Y Oliveira; Melissa Cipolla; Charlotte Viant; Christopher O Barnes; Yaron Bram; Gaëlle Breton; Thomas Hägglöf; Pilar Mendoza; Arlene Hurley; Martina Turroja; Kristie Gordon; Katrina G Millard; Victor Ramos; Fabian Schmidt; Yiska Weisblum; Divya Jha; Michael Tankelevich; Gustavo Martinez-Delgado; Jim Yee; Roshni Patel; Juan Dizon; Cecille Unson-O'Brien; Irina Shimeliovich; Davide F Robbiani; Zhen Zhao; Anna Gazumyan; Robert E Schwartz; Theodora Hatziioannou; Pamela J Bjorkman; Saurabh Mehandru; Paul D Bieniasz; Marina Caskey; Michel C Nussenzweig
Journal:  Nature       Date:  2021-01-18       Impact factor: 69.504

7.  Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Authors:  Jennifer M Dan; Jose Mateus; Yu Kato; Kathryn M Hastie; Esther Dawen Yu; Caterina E Faliti; Alba Grifoni; Sydney I Ramirez; Sonya Haupt; April Frazier; Catherine Nakao; Vamseedhar Rayaprolu; Stephen A Rawlings; Bjoern Peters; Florian Krammer; Viviana Simon; Erica Ollmann Saphire; Davey M Smith; Daniela Weiskopf; Alessandro Sette; Shane Crotty
Journal:  Science       Date:  2021-01-06       Impact factor: 47.728

8.  BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.

Authors:  Noa Dagan; Noam Barda; Eldad Kepten; Oren Miron; Shay Perchik; Mark A Katz; Miguel A Hernán; Marc Lipsitch; Ben Reis; Ran D Balicer
Journal:  N Engl J Med       Date:  2021-02-24       Impact factor: 91.245

9.  Impact of age, ethnicity, sex and prior infection status on immunogenicity following a single dose of the BNT162b2 mRNA COVID-19 vaccine: real-world evidence from healthcare workers, Israel, December 2020 to January 2021.

Authors:  Kamal Abu Jabal; Hila Ben-Amram; Karine Beiruti; Yunis Batheesh; Christian Sussan; Salman Zarka; Michael Edelstein
Journal:  Euro Surveill       Date:  2021-02

Review 10.  Antibody and B cell responses to SARS-CoV-2 infection and vaccination.

Authors:  Katharina Röltgen; Scott D Boyd
Journal:  Cell Host Microbe       Date:  2021-06-17       Impact factor: 21.023
View more
  2 in total

Review 1.  Mutational Pattern, Impacts and Potential Preventive Strategies of Omicron SARS-CoV-2 Variant Infection.

Authors:  Endeshaw Chekol Abebe; Markeshaw Tiruneh G/Medhin; Awgichew Behaile T/Mariam; Tadesse Asmamaw Dejenie; Teklie Mengie Ayele; Fitalew Tadele Admasu; Zelalem Tilahun Muche; Getachew Asmare Adela
Journal:  Infect Drug Resist       Date:  2022-04-15       Impact factor: 4.177

2.  Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine.

Authors:  Bruna Lo Sasso; Luisa Agnello; Rosaria Vincenza Giglio; Caterina Maria Gambino; Anna Maria Ciaccio; Matteo Vidali; Marcello Ciaccio
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.